Science Explorer Back to mapMap

Most cited papers from Missouri Valley Cancer Consortium

What are the most cited papers from Missouri Valley Cancer Consortium?

The most cited paper from Missouri Valley Cancer Consortium is "Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial" (Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al., 2000), with 739 citations. Next come "Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study" (364) and "Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy" (362).

Showing 50 of 74 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Charles L. Loprinzi, John W. Kugler, Jeff A Sloan et al. · The Lancet Dec 2000 739
2 Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi et al. · Journal of Clinical Oncology 15 Jan 2002 364
3 Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy Ravi D. Rao, John C. Michalak, Jeff A. Sloan et al. · Cancer 12 Sep 2007 362
4 Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial Carmen Joseph Allegra et al. · JNCI Journal of the National Cancer Institute Open access 14 Sep 2015 331
5 An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients With Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi et al. · Journal of Clinical Oncology 15 Jun 2004 299
6 A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Debra L. Barton, Edward J. Wos, Rui Qin et al. · Supportive Care in Cancer Open access 24 May 2010 255
7 Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Julie E. Hammack, John C. Michalak, Charles L. Loprinzi et al. · Pain Jul 2002 231
8 Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA Debra L. Barton, Gamini S. Soori, Brent A. Bauer et al. · Supportive Care in Cancer Open access 5 May 2009 216
9 Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet Open access 15 Dec 2015 199
10 Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy Ravi D. Rao, Patrick J. Flynn, Jeff A. Sloan et al. · Cancer 21 Apr 2008 195
11 Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial Amanda R. Moraska, Amit Sood, Shaker R. Dakhil et al. · Journal of Clinical Oncology Open access 13 Jul 2010 173
12 The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak et al. · Supportive Care in Cancer Open access 9 Oct 2010 173
13 Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial Eleftherios P. Mamounas, Hanna Bandos, Barry C. Lembersky et al. · The Lancet Oncology Open access 30 Nov 2018 170
14 Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer Steven E. Schild, James A. Bonner, Thomas G. Shanahan et al. · International Journal of Radiation Oncology*Biology*Physics Jul 2004 168
15 Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy Brandi Reeves, Shaker R. Dakhil, Jeff A. Sloan et al. · Cancer Open access 13 Mar 2012 162
16 A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study Grace Kho Dy, Antonius Arthur Miller, Sumithra J. Mandrekar et al. · Annals of Oncology Open access 9 Aug 2005 150
17 A placebo‐controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome Aminah Jatoi, Shaker R. Dakhil, Phuong Nguyen et al. · Cancer Open access 2 Aug 2007 138
18 Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma Ivana N. Micallef, Matthew J. Maurer, Gregory A. Wiseman et al. · Blood Open access 15 Jun 2011 138
19 Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252 Edith A. Perez, Vera Jean Suman, Kendrith M. Rowland et al. · Clinical Breast Cancer Dec 2005 137
20 Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations Wee Joo Chng, Rafael Santana-Dávila, Scott A. Van Wier et al. · Leukemia 2 Mar 2006 137
21 The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA Sherry L. Wolf, Debra L. Barton, Rui Qin et al. · Supportive Care in Cancer Open access 12 Apr 2011 126
22 Randomized Phase II Study of Two Irinotecan Schedules for Patients With Metastatic Breast Cancer Refractory to an Anthracycline, a Taxane, or Both Edith A. Perez, David W. Hillman, James A. Mailliard et al. · Journal of Clinical Oncology Open access 14 Jul 2004 124
23 Does Zinc Sulfate Prevent Therapy-Induced Taste Alterations in Head and Neck Cancer Patients? Results of Phase III Double-Blind, Placebo-Controlled Trial from the North Central Cancer Treatment Group (N01C4) Michele Y. Halyard, Aminah Jatoi, Jeff A. Sloan et al. · International Journal of Radiation Oncology*Biology*Physics 29 Mar 2007 119
24 Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7 Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Journal of Clinical Oncology 27 Feb 2006 118
25 Outcomes Among African-American/Non-African-American Patients With Advanced Non-Small-Cell Lung Carcinoma: Report From the Cancer and Leukemia Group B A. William Blackstock, James E. Herndon, Electra D. Paskett et al. · JNCI Journal of the National Cancer Institute 20 Feb 2002 108
26 A prognostic model for advanced stage nonsmall cell lung cancer Sumithra J. Mandrekar, Steven E. Schild, Shauna L. Hillman et al. · Cancer 17 Jul 2006 108
27 Evaluation of shark cartilage in patients with advanced cancer Charles L. Loprinzi, Ralph Levitt, Debra L. Barton et al. · Cancer 24 May 2005 97
28 Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer 1 1This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Additional participating institutions included Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA; Meritcare Hospital CCOP, Fargo, ND; Sioux Community Cancer Con Steven E. Schild, Philip J. Stella, Susan Michelle Geyer et al. · International Journal of Radiation Oncology*Biology*Physics Open access Oct 2002 93
29 Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly Steven E. Schild, Philip J. Stella, Burke J. Brooks et al. · Cancer Open access 25 Apr 2005 87
30 A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma Edith A. Perez, David W. Hillman, Philip J. Stella et al. · Cancer Open access 2000 86
31 Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet Open access 16 Dec 2015 79
32 Mortality associated with daily bolus 5‐fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin Thierry Delaunoit, Richard M. Goldberg, Daniel J. Sargent et al. · Cancer Open access 6 Oct 2004 78
33 Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck Ron R. Allison, Aaron A. Ambrad, Youssef Arshoun et al. · Cancer Open access 11 Feb 2014 77
34 Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study Steven R. Alberts, P. Townley, Richard M. Goldberg et al. · Annals of Oncology Open access 20 Mar 2003 70
35 Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53) Steven E. Schild, James A. Bonner, Shauna L. Hillman et al. · Journal of Clinical Oncology 18 Jul 2007 69
36 Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51) Elizabeth Anne Johnson, Randolph S. Marks, Sumithra J. Mandrekar et al. · Lung Cancer 6 Dec 2007 69
37 The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 Debra L. Barton, Kelli N. Burger, Paul J. Novotny et al. · Supportive Care in Cancer Open access 12 Nov 2012 65
38 A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma James N. Ingle, PATRICIA A. JOHNSON, Vera Jean Suman et al. · Cancer Open access 15 Jul 1997 64
39 Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer Yingwei Qi, Steven E. Schild, Sumithra J. Mandrekar et al. · Journal of Thoracic Oncology Open access Sep 2009 64
40 A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma James N. Ingle, Vera Jean Suman, Carl G. Kardinal et al. · Cancer Open access 15 Mar 1999 62
41 Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting Gary A. Croghan, Jeff A. Sloan, Ivana T. Croghan et al. · Nicotine & Tobacco Research 2003 60
42 A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422) Aminah Jatoi, Steven E. Schild, Nathan R. Foster et al. · Annals of Oncology Open access 22 Jun 2010 56
43 Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group Karin F. Giordano, Aminah Jatoi, Philip J. Stella et al. · Annals of Oncology Open access 24 Feb 2006 51
44 Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study Mansoina Baweja, Vera Jean Suman, Tom R. Fitch et al. · Annals of Oncology Open access 7 Mar 2006 39
45 A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia Aminah Jatoi, Marisa Tria Tirona, Steven S. Cha et al. · International Journal of Gastrointestinal Cancer 2002 34
46 Patient Assessment of Bowel Function During and After Pelvic Radiotherapy: Results of a Prospective Phase III North Central Cancer Treatment Group Clinical Trial Michael G. Haddock, Jeff A. Sloan, John William Bollinger et al. · Journal of Clinical Oncology 30 Mar 2007 33
47 Ploidy status rarely changes in myeloma patients at disease progression Wee Joo Chng, Jerry M. Winkler, Philip R. Greipp et al. · Leukemia Research 19 Aug 2005 33
48 Phase II Study of Gemcitabine Plus Cisplatin in Patients With Metastatic Breast Cancer Patrick A. Burch, James A. Mailliard, David W. Hillman et al. · American Journal of Clinical Oncology 31 Mar 2005 31
49 Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age) Aminah Jatoi, Philip J. Stella, Shauna H. Hillman et al. · American Journal of Clinical Oncology Oct 2003 30
50 Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study Steven R. Alberts, P. Townley, Richard M. Goldberg et al. · Annals of Oncology Open access Apr 2002 27

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.